Stockreport

AMEDICA ANNOUNCES FILING OF KEY PATENT APPLICATION RELATING TO THE ANTI-VIRAL EFFECT OF ITS SILICON NITRIDE

AMEDICA CORP COMMON STOCK  (AMDA) 
US:NASDAQ Investor Relations: investors.amedica.com
PDF SALT LAKE CITY, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Amedica Corporation (NASDAQ: AMDA), a company that develops and commercializes silicon nitride for biomedical applic [Read more]